Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1306
Selected: 0
NCT IDTitle
NCT03709225Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer
NCT03777410Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
NCT05234983Adapting and Evaluating a Brief Advice Tobacco Intervention in High-Reach, Low-Resource Settings in India
NCT01522768Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
NCT02337491Pembrolizumab +/- Bevacizumab for Recurrent GBM
NCT00215046Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis
NCT00004180Rosiglitazone in Treating Patients With Liposarcoma
NCT04469556Pancreatic Adenocarcinoma Signature Stratification for Treatment
NCT04863157Survivor-Sleep Health Information Program
NCT06844383A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
NCT05825469Development and Testing of Nutritional Algorithms (NACHO)
NCT04354454Step Into Support for Endurance and Strength (SISTERS)
NCT05281237Avecure Flexible Microwave Ablation Probe For Lung Nodules
NCT02623972A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
NCT01068769Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
NCT03101254LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
NCT04356729A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
NCT05349227Comprehensive Outcomes for After Cancer Health
NCT06716580EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
NCT00895661High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
NCT02041429Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
NCT02478164Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
NCT05296512Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
NCT03236428Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
NCT07601100Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma
NCT06117709Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
NCT01786811Serious Illness Communication Project
NCT03495323A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
NCT06303713LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
NCT00006123Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT02720679Investigation of the Genetics of Hematologic Diseases
NCT02474368Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
NCT02340676A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD
NCT03532971Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
NCT00797732A Pilot Study of Acupuncture Treatment for Dysphagia
NCT06351332ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC
NCT03085719Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
NCT02865811Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
NCT00997334Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC
NCT00146601Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
NCT02036476Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
NCT00908960Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
NCT01331291Bosutinib in Adult Patients With Recurrent Glioblastoma
NCT00749320Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
NCT00593008Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer
NCT02470910Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
NCT02158091A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
NCT00165217Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma
NCT06468618Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
NCT04485767RESIST-ADT (Androgen Deprivation Therapy)